Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review

Date: April 26, 2016
Pages: 64
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IF4D286E4F3EN
Leaflet:

Download PDF Leaflet

Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review
Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Integra LifeSciences Holdings Corporation (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corporation Key Recent Developments

Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
Feb 25, 2016: Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health
Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results
Sep 15, 2015: Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology
Sep 01, 2015: Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Integra LifeSciences Holdings Corporation - Key Facts
    Integra LifeSciences Holdings Corporation - Key Employees
    Integra LifeSciences Holdings Corporation - Key Employee Biographies
    Integra LifeSciences Holdings Corporation - Major Products and Services
    Integra LifeSciences Holdings Corporation - History
    Integra LifeSciences Holdings Corporation - Company Statement
    Integra LifeSciences Holdings Corporation - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Integra LifeSciences Holdings Corporation - Key Manufacturing Facilities

    SECTION 2 – COMPANY ANALYSIS

    Integra LifeSciences Holdings Corporation - Business Description
    Business Description - Orthopedics and Tissue Technologies
    Orthopedics and Tissue Technologies - Overview
    Orthopedics and Tissue Technologies - Financials
    Business Description - Specialty Surgical Solutions
    Specialty Surgical Solutions - Overview
    Specialty Surgical Solutions - Financials
    Integra LifeSciences Holdings Corporation - Corporate Strategy
    Integra LifeSciences Holdings Corporation - SWOT Analysis
    SWOT Analysis - Overview
    Integra LifeSciences Holdings Corporation - Strengths
    Strength - Research and Development
    Strength - Specialty Surgical Solutions Segment
    Strength - Established Presence in Domestic Market
    Integra LifeSciences Holdings Corporation - Weaknesses
    Weakness - Declining Net Working Capital
    Weakness - Product Safety Concerns
    Integra LifeSciences Holdings Corporation - Opportunities
    Opportunity - Strategic Acquisitions
    Opportunity - Strategic Initiatives
    Opportunity - Neurology Devices Market
    Opportunity - Global Wound Care Management Market
    Integra LifeSciences Holdings Corporation - Threats
    Threat - Stringent Government Regulations
    Threat - Competitive Environment
    Threat - Raw Materials Derived from Animal Sources
    Integra LifeSciences Holdings Corporation - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance
    Feb 25, 2016: Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health
    Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results
    Sep 15, 2015: Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology
    Sep 01, 2015: Integra LifeSciences Announces Expansion of Credit Facility to $1.1 Billion
    Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results
    Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine
    Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine
    Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results
    Apr 01, 2015: Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Integra LifeSciences Holdings Corporation, Key Facts
    Integra LifeSciences Holdings Corporation, Key Employees
    Integra LifeSciences Holdings Corporation, Key Employee Biographies
    Integra LifeSciences Holdings Corporation, Major Products and Services
    Integra LifeSciences Holdings Corporation, History
    Integra LifeSciences Holdings Corporation, Other Locations
    Integra LifeSciences Holdings Corporation, Subsidiaries
    Integra LifeSciences Holdings Corporation, Key Manufacturing Facilities
    Integra LifeSciences Holdings Corporation, Key Competitors
    Integra LifeSciences Holdings Corporation, Ratios based on current share price
    Integra LifeSciences Holdings Corporation, Annual Ratios
    Integra LifeSciences Holdings Corporation, Interim Ratios
    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Integra LifeSciences Holdings Corporation, Performance Chart (2011 - 2015)
    Integra LifeSciences Holdings Corporation, Ratio Charts
    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Integra LifeSciences Holdings Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Integra LifeSciences Holdings Corporation (IART) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: